Allopurinol and Quality of Life in Liver Cirrhosis
NCT05828836 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2023-10-31
Summary
The study aims to evaluate the impact of allopurinol on patients' related quality of life.
Conditions
- Cirrhosis, Liver
Interventions
- DRUG
-
Allopurinol Tablet
allopurinol300mg once daily
- DRUG
-
placebo once daily
Sponsors & Collaborators
-
Tanta University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-15
- Primary Completion
- 2023-01-15
- Completion
- 2023-03-01
Countries
- Egypt
Study Locations
More Related Trials
-
Liver Injury in Patients With COVID-19
NCT04358380 ·Status: UNKNOWN
-
Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis
NCT05033327 ·Status: COMPLETED ·Phase: NA
-
Pattern and Short Term Outcomes of Renal Affection in Patients With Liver Cirrhosis in Al-Rajhi Liver Hospital
NCT06924294 ·Status: NOT_YET_RECRUITING
-
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
NCT06953921 ·Status: RECRUITING
-
Acute Liver Injury in Patients With Pneumonia
NCT06103981 ·Status: NOT_YET_RECRUITING
-
Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
NCT07053709 ·Status: NOT_YET_RECRUITING
-
Short-term Survival in Patients With Severe Alcoholic Hepatitis Treated With Steroid Versus Pentoxifylline
NCT01455337 ·Status: UNKNOWN ·Phase: PHASE3
-
The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis
NCT06470386 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
NCT04806581 ·Status: UNKNOWN ·Phase: PHASE1
-
Medication Adherence in Patients With Liver Cirrhosis
NCT03627338 ·Status: UNKNOWN
-
Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions
NCT03172650 ·Status: UNKNOWN
-
Prediction of SBP in Cirrhotic Patients by Platlet Count, Na and AlBl Index.
NCT07116369 ·Status: NOT_YET_RECRUITING
-
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects
NCT05249374 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites
NCT04058613 ·Status: UNKNOWN ·Phase: NA
-
Stem Cell Transplantation in Cirrhotic Patients
NCT02943889 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Care Algorithm and Clinic Decision System on Hepatic Rehabilitation in Patients With Liver Cirrhosis
NCT06995196 ·Status: COMPLETED ·Phase: NA
-
Role of ALBI Score and Sarcopenia As Prognostic Predictors Among Hospitalized Cirrhotic Patients with Hepatic Encephalopathy
NCT06679868 ·Status: NOT_YET_RECRUITING
-
Comparative Study of Novel Prognostic Scores in Patients With Liver Cirrhosis
NCT07238543 ·Status: NOT_YET_RECRUITING
-
Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.
NCT04391764 ·Status: COMPLETED ·Phase: NA
-
The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study
NCT05508633 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
NCT00886925 ·Status: COMPLETED ·Phase: PHASE4
-
Acute-On-Chronic Liver Failure In Cirrhotic Patients
NCT04790435 ·Status: COMPLETED
-
Description of the Evolution of Plasma and Urinary Concentrations of Iohexol in a Cirrhotic Patient Population
NCT03769597 ·Status: COMPLETED ·Phase: PHASE4
-
Complex Exploratory Study of Alcohol-Associated Hepatitis
NCT06358196 ·Status: NOT_YET_RECRUITING
-
Assessment of Severity of Liver Disease Before Surgery
NCT05503836 ·Status: UNKNOWN